Keenova Therapeutics plc Restricted Cash, Current
Keenova Therapeutics plc had Restricted Cash, Current of $112.10 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Restricted Cash and Investments, Current
us-gaap:RestrictedCashCurrent · last filed 2026-08-11
- 2026-06-30: Restricted Cash, Current $112.10M.
- 2026-03-31: Restricted Cash, Current $110.80M.
- 2025-12-31: Restricted Cash, Current $111.40M.
- 2025-06-27: Restricted Cash, Current $19.50M.
| Period end | Restricted Cash, Current |
|---|---|
| 2026-06-30 | $112.10M 10-Q · filed 2026-08-11 |
| 2026-03-31 | $110.80M 10-Q · filed 2026-05-12 |
| 2025-12-31 | $111.40M 10-K · filed 2026-04-15 |
| 2025-06-27 | $19.50M 10-Q · filed 2026-08-11 |
| 2025-03-28 | $21.70M 10-Q · filed 2026-05-12 |
| 2024-12-27 | $21.50M 10-K · filed 2026-04-15 |
| 2023-12-29 | $40.80M 10-K · filed 2026-04-15 |
| 2023-11-14 | $47.00M 10-K · filed 2026-04-15 |